Lu-PSMA-617

DRUG3 trials

Sponsors

Angela Y. Jia, MD PhD, Case Comprehensive Cancer Center, Melissa Lumish

Conditions

Hepatocellular CarcinomaLiver CancerLocally Advanced Prostate CancerMalignant Neoplasm of ProstateMetastatic Castration-resistant Prostate CancerMetastatic Liver CancerMetastatic Prostate Cancer

Phase 1

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

RecruitingNCT06574880

Angela Y. Jia, MD PhDLocally Advanced Prostate Cancer, Malignant Neoplasm of Prostate

Start: 2025-05-13End: 2027-03-01Target: 45Updated: 2026-05-26

Phase 2

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

RecruitingNCT06738303

Case Comprehensive Cancer CenterMetastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer

Start: 2025-07-14End: 2026-12-01Target: 44Updated: 2026-08-14

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

RecruitingNCT06852820

Melissa LumishHepatocellular Carcinoma, Liver Cancer, Metastatic Liver Cancer

Start: 2026-06-01End: 2027-04-01Target: 10Updated: 2026-05-08